3181 - 3190 of 8808 Results
Title
Year
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
-
OPENTitle: Minimalist approaches to cancer tissue-of-origin classification by DNA methylationJournal Name: Modern PathologyPublisher: Elsevier BVVol: 33Issue #: 10Start Page: 1874End Page: 1888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41379-020-0547-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8808378Citation Count: 35
-
OPENTitle: Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.750767Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.750767/pdfCitation Count: 19
-
OPENTitle: Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD)Journal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 62End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12010062Best OA location URL: https://www.mdpi.com/2076-3425/12/1/62/pdf?version=1641260939Citation Count: 9
-
OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8770717Citation Count: 9
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 31
-
OPENTitle: PhosPiR: an automated phosphoproteomic pipeline in RJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbab510Best OA location URL: https://academic.oup.com/bib/article-pdf/23/1/bbab510/43308900/bbab510.pdfCitation Count: 9
-
OPENTitle: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patientsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03032-5Best OA location URL: https://www.nature.com/articles/s42003-022-03032-5.pdfCitation Count: 28
-
OPENTitle: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2022Issue #: 1Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5597503Best OA location URL: https://downloads.hindawi.com/journals/pd/2022/5597503.pdfCitation Count: 4
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 87